I guess I thought that the Philippines was going to really step up and be ahead of the curve when it came to using leronlimab. Once we have CD12 results, if they are good, EVERY country will want leronlimab and there might not even be enough in the first year to treat all of the Americans who need it.

Amazes me that given what we DO seem to know about how effective (and safe!) leronlimab is, no country has been forward-thinking enough to be first in line without having every little shred of evidence from CD12. We are beyond crisis mode here in Los Angeles, not to mention the rest of the world...